WNT11 and melanoma: FZD7 has been implicated in tumor aggressiveness through the Wnt/PCP pathway in ovarian cancer [39], and its upregulation during melanoma progression suggests a role in inducing tumorigenesis and tumor growth by WNT11-FZD7-DAAM1 signaling [40].